Details of the Drug Reposition

General Information of This Drug (ID: DMQZ9GF)

Drug Name
Trilostane   DMQZ9GF
Synonyms
Desopan; Desopan (TN); Modrenal (TN); Vetoryl (TN); Vetoryl, Trilostane; Win-24540; Trilostane (JAN/USAN); (4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile; 3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Adrenal gland hyperfunction DISPP4ZK N.A. Discontinued in Phase 3 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cushing disease DISOG6P2 5A70 Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------

References

1 A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .
2 Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia